Kestra Medical Technologies (NASDAQ:KMTS) Shares Gap Up - Still a Buy?

Key Points

• Kestra Medical Technologies shares gapped up on Tuesday, opening at $19.39 (prior close $18.33) and last trading around $19.01 on ~62,765 shares, while analysts' average target is $28.80 and the consensus rating is a "Hold" despite several Buy/Overweight calls.
• The company reported revenue of $24.55 million (up 62.7% year‑over‑year) but remains unprofitable, posting a ($0.61) EPS miss and a negative net margin of 171.87% and negative ROE of 65.49%.
• Insiders have been net sellers recently—including Brian Daniel Webster's sale of 15,000 shares—and insiders sold 45,000 shares in the last three months, with insiders owning about 3.6% of the stock.

Kestra Medical Technologies, Ltd. (NASDAQ:KMTS - Get Free Report)'s share price gapped up prior to trading on Tuesday . The stock had previously closed at $18.33, but opened at $19.39. Kestra Medical Technologies shares last traded at $19.0050, with a volume of 62,765 shares traded.

Wall Street Analyst Weigh In

Several research analysts have issued reports on the company. BTIG Research restated a "buy" rating and set a $32.00 target price on shares of Kestra Medical Technologies in a research report on Wednesday, March 25th. Stifel Nicolaus set a $30.00 price target on Kestra Medical Technologies in a research note on Friday, December 12th. Piper Sandler boosted their price objective on Kestra Medical Technologies from $27.00 to $30.00 and gave the company an "overweight" rating in a report on Friday, December 12th. Wells Fargo & Company upped their price objective on Kestra Medical Technologies from $27.00 to $28.00 and gave the company an "overweight" rating in a research report on Friday, December 12th. Finally, The Goldman Sachs Group set a $24.00 target price on Kestra Medical Technologies in a research note on Friday, January 16th. Three research analysts have rated the stock with a Buy rating, one has given a Hold rating and one has given a Sell rating to the company. According to MarketBeat.com, the company presently has an average rating of "Hold" and an average target price of $28.80.

Kestra Medical Technologies Stock Up 3.2%

The company has a debt-to-equity ratio of 0.15, a quick ratio of 7.32 and a current ratio of 7.32. The company has a fifty day simple moving average of $23.58 and a two-hundred day simple moving average of $24.72. The firm has a market capitalization of $1.10 billion and a PE ratio of -4.75.

Kestra Medical Technologies (NASDAQ:KMTS - Get Free Report) last announced its quarterly earnings results on Tuesday, March 17th. The company reported ($0.61) EPS for the quarter, missing the consensus estimate of ($0.60) by ($0.01). Kestra Medical Technologies had a negative net margin of 171.87% and a negative return on equity of 65.49%. The firm had revenue of $24.55 million for the quarter. The business's revenue for the quarter was up 62.7% on a year-over-year basis.

Insider Activity at Kestra Medical Technologies

In other news, insider Brian Daniel Webster sold 15,000 shares of the company's stock in a transaction that occurred on Tuesday, March 17th. The shares were sold at an average price of $20.27, for a total value of $304,050.00. Following the completion of the sale, the insider owned 364,786 shares of the company's stock, valued at approximately $7,394,212.22. This represents a 3.95% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. In the last three months, insiders have sold 45,000 shares of company stock valued at $1,030,050. Insiders own 3.60% of the company's stock.

Hedge Funds Weigh In On Kestra Medical Technologies

Large investors have recently bought and sold shares of the business. Farther Finance Advisors LLC purchased a new stake in Kestra Medical Technologies during the fourth quarter worth $31,000. Russell Investments Group Ltd. increased its holdings in shares of Kestra Medical Technologies by 43.5% in the 4th quarter. Russell Investments Group Ltd. now owns 1,563 shares of the company's stock valued at $41,000 after acquiring an additional 474 shares during the period. China Universal Asset Management Co. Ltd. bought a new position in shares of Kestra Medical Technologies in the 3rd quarter worth $48,000. Police & Firemen s Retirement System of New Jersey bought a new position in shares of Kestra Medical Technologies in the 2nd quarter worth $54,000. Finally, BNP Paribas Financial Markets lifted its stake in shares of Kestra Medical Technologies by 148.9% during the 3rd quarter. BNP Paribas Financial Markets now owns 2,738 shares of the company's stock worth $65,000 after purchasing an additional 1,638 shares during the last quarter.

Kestra Medical Technologies Company Profile

We are a commercial-stage, wearable medical device and digital healthcare company focused on transforming patient outcomes in cardiovascular disease using monitoring and therapeutic intervention technologies that are intuitive, intelligent, and connected. We have developed and are commercializing our Cardiac Recovery System platform, a comprehensive and advanced system that integrates monitoring, therapeutic treatment, digital health, and patient support services into a single, unified solution. The cornerstone of our Cardiac Recovery System platform is the ASSURE WCD, a next generation wearable cardioverter defibrillator (“WCD”) used to protect patients at an elevated risk of sudden cardiac arrest (“SCA”), a major public health problem that accounts for approximately 50% of all cardiovascular deaths in the U.S.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.